Development of Myelo001 as an Orally Applied Medical Countermeasure for the Treatment of Hematopoietic Acute Radiation Syndrome
Award Notice Posted
- Solicitation number
- HHS-NIH-NIAID-BAA2019-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Myelo Therapeutics GMBH
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00005 Federal contract award
- NAICS code
- Not on record
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
The Award Notice was published by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases on February 2, 2021 for the development of Myelo001 as an orally applied medical countermeasure for the treatment of hematopoietic acute radiation syndrome. Under the awarded contract 75N93020C00005, MYELO THERAPEUTICS GMBH will receive $5,958,823 to develop Myelo001 as an oral treatment for those exposed to high doses of radiation within 60 days to mitigate hematopoietic acute radiation syndrome and increase survival.
Notice text
Awarded contract 75N93020C00005 to MYELO THERAPEUTICS GMBH for 5958823.00 on 2020-04-30.
Notice history
| Notice | Type | Posted |
|---|---|---|
| HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 003, Advanced Development of Vaccine Candidates for Antibiotic Resistant Bacteria | Award Notice | |
| HHS-NIH-NIAID-BAA2019-1: Research Area 002, Development of Therapeutic Products for Antibiotic Resistant Bacteria | Award Notice | |
| This notice | Award Notice | |
| 2019 NIAID Omnibus Broad Agency Announcement | Pre-Solicitation | |
| 2019 NIAID Omnibus Broad Agency Announcement | Special Notice |
6 of 11 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity